Cargando…
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition
We report here the successful vectorization of a hamster monoclonal IgG (namely J43) recognizing the murine Programmed cell death-1 (mPD-1) in Western Reserve (WR) oncolytic vaccinia virus. Three forms of mPD-1 binders have been inserted into the virus: whole antibody (mAb), Fragment antigen-binding...
Autores principales: | Kleinpeter, Patricia, Fend, Laetitia, Thioudellet, Christine, Geist, Michel, Sfrontato, Nathalie, Koerper, Véronique, Fahrner, Catherine, Schmitt, Doris, Gantzer, Murielle, Remy-Ziller, Christelle, Brandely, Renée, Villeval, Dominique, Rittner, Karola, Silvestre, Nathalie, Erbs, Philippe, Zitvogel, Laurence, Quéméneur, Eric, Préville, Xavier, Marchand, Jean-Baptiste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087307/ https://www.ncbi.nlm.nih.gov/pubmed/27853644 http://dx.doi.org/10.1080/2162402X.2016.1220467 |
Ejemplares similares
-
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model
por: Remy-Ziller, Christelle, et al.
Publicado: (2017) -
By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1
por: Kleinpeter, Patricia, et al.
Publicado: (2019) -
Intravenous injection of a modified vaccinia ankara virus induces intratumoral CD8+ lymphocyte infiltration favoring tumor control in an orthotopic tumor model upon combinatorial treatment with a TLR9 agonist
por: Fend, Laetitia, et al.
Publicado: (2014) -
Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand
por: Préville, Xavier, et al.
Publicado: (2015) -
Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in Pichia pastoris
por: Schoonooghe, Steve, et al.
Publicado: (2009)